Literature DB >> 2844556

Verapamil, neuromuscular transmission and the nicotinic receptor.

R O Edeson1, B W Madsen, R K Milne, A C Le Dain.   

Abstract

The effect of verapamil on neuromuscular transmission was studied in the frog by analysing ionophoretic endplate current (iEPC) trains and the growth and decay phases of miniature endplate currents (mepcs). In addition, single channel data on the interaction of verapamil with the nicotinic acetylcholine receptor were obtained from cultured embryonic chick skeletal muscle cells. Verapamil caused both open and closed channel blockade in the iEPC trains. Mepc amplitude was decreased at low micromolar concentrations, and at higher concentrations there was also accelerated mepc decay indicating open channel blockade. The latter effect could not be explained by a sequential channel occlusion mechanism. Analysis of the mepc rising phase showed that low micromolar concentrations of the drug decreased the pool of receptors which could be activated. Single channel data confirmed the specific interaction of verapamil with the nicotinic receptor, showing closed channel blockade at low concentrations, and at higher levels the shortening of open channel lifetime. It is suggested that both forms of blockade may involve desensitization processes.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2844556     DOI: 10.1016/0014-2999(88)90812-6

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  4 in total

1.  Inhibition of neurally-evoked transmitter release by calcium channel antagonists in rat parasympathetic ganglia.

Authors:  G R Seabrook; D J Adams
Journal:  Br J Pharmacol       Date:  1989-08       Impact factor: 8.739

2.  Factors influencing the low-frequency associated nicotinic ACh autoreceptor-mediated depression of ACh release from rat motor nerve terminals.

Authors:  C Prior; S Singh
Journal:  Br J Pharmacol       Date:  2000-03       Impact factor: 8.739

3.  Kinetics of (+)-tubocurarine blockade at the neuromuscular junction.

Authors:  A C Le Dain; B W Madsen; R O Edeson
Journal:  Br J Pharmacol       Date:  1991-06       Impact factor: 8.739

4.  Pre- and postsynaptic effects of the calcium channel blocker verapamil at neuromuscular junctions.

Authors:  E R Sharifullina; R A Afzalov; M V Talantova; F Vyskochil; R A Giniatullin
Journal:  Neurosci Behav Physiol       Date:  2002 May-Jun
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.